Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double-blind study in healthy adults.
Saved in:
| Title: | Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double-blind study in healthy adults. |
|---|---|
| Authors: | Bodie S; Pulmatrix Inc., Bedford, Massachusetts, USA., Curran AK; Pulmatrix Inc., Bedford, Massachusetts, USA., Gonzalez-Nelson AC; Pulmatrix Inc., Bedford, Massachusetts, USA., Perry JM; Pulmatrix Inc., Bedford, Massachusetts, USA., Manning DC; Veristat, Southborough, Massachusetts, USA., Wasilewski MM; Pulmatrix Inc., Bedford, Massachusetts, USA. |
| Source: | Headache [Headache] 2024 Jun; Vol. 64 (6), pp. 643-651. Date of Electronic Publication: 2024 May 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Comparative Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1526-4610 |
|---|---|
| DOI: | 10.1111/head.14731 |
